Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Spratt

Showing results (461-470 of 666) with videos related to

Pageof 67
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2021
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trialA A Hamid, H-C Huang, V Wang, et al.
The Lancet. Oncology|December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium reportDaniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
European Urology|July 8, 2018
Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell CarcinomaAaron M Udager, Andrew S McDaniel, Daniel H Hovelson, et al.
Human Pathology|December 12, 2018
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinomaCaroline T Simon, Stephanie L Skala, Alon Z Weizer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
Pivotal role for the ubiquitin Y59-E51 loop in lysine 48 polyubiquitinationRobert A Chong, Kenneth Wu, Donald E Spratt, et al.
JAMA Network Open|October 15, 2024
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical TrialSoumyajit Roy, Shawn Malone, Kevin Wing, et al.
Cancer|January 7, 2020
Genomic and clinical characterization of stromal infiltration markers in prostate cancerBrandon A Mahal, Mohammed Alshalalfa, Shuang G Zhao, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
The Journal of Urology|July 26, 2024
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN TrialSoumyajit Roy, Yilun Sun, Kim N Chi, et al.
Pageof 67

Showing results (461-470 of 666) with videos related to

Sort By:
Pageof 67
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 15, 2021
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trialA A Hamid, H-C Huang, V Wang, et al.
The Lancet. Oncology|December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium reportDaniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
European Urology|July 8, 2018
Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell CarcinomaAaron M Udager, Andrew S McDaniel, Daniel H Hovelson, et al.
Human Pathology|December 12, 2018
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinomaCaroline T Simon, Stephanie L Skala, Alon Z Weizer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2014
Pivotal role for the ubiquitin Y59-E51 loop in lysine 48 polyubiquitinationRobert A Chong, Kenneth Wu, Donald E Spratt, et al.
JAMA Network Open|October 15, 2024
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical TrialSoumyajit Roy, Shawn Malone, Kevin Wing, et al.
Cancer|January 7, 2020
Genomic and clinical characterization of stromal infiltration markers in prostate cancerBrandon A Mahal, Mohammed Alshalalfa, Shuang G Zhao, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
The Journal of Urology|July 26, 2024
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN TrialSoumyajit Roy, Yilun Sun, Kim N Chi, et al.
Pageof 67